Two Sigma Securities, LLC Outlook Therapeutics, Inc. Transaction History

Two Sigma Securities, LLC

  • $10.3 Billion
  • Q1 2024

Shares

4 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2023

Nov 14, 2023
BUY
$0.2 - $1.78 $667 - $5,936
3,335 Added 26.69%
15,832 $3,000
Q2 2023

Aug 14, 2023
BUY
$1.02 - $1.89 $12,746 - $23,619
12,497 New
12,497 $21,000
Q2 2021

Aug 16, 2021
SELL
$1.78 - $2.76 $22,159 - $34,359
-12,449 Closed
0 $0
Q1 2021

May 17, 2021
BUY
$0.94 - $3.31 $11,702 - $41,206
12,449 New
12,449 $28,000

Others Institutions Holding OTLK

# of Institutions
7
Shares Held
67.1K
Call Options Held
0
Put Options Held
0
View Full List

About Outlook Therapeutics, Inc.

OTLK Quotes by TradingView
  • Ticker OTLK
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 226,144,992
  • Market Cap $1.66B
  • Description
  • Outlook Therapeutics, Inc., a late clinical-stage biopharmaceutical company, focuses on developing and commercializing monoclonal antibodies for various ophthalmic indications. Its lead product candidate is ONS-5010, an ophthalmic formulation of bevacizumab product candidate that is in Phase-III clinical trial for the treatment of wet age-relate...
More about OTLK
Track This Portfolio

Track Two Sigma Securities, LLC Portfolio

Follow Two Sigma Securities, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Two Sigma Securities, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Two Sigma Securities, LLC with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email